CD40LG and X-linked lymphoproliferative disease: Conclusive molecular diagnoses resulted in clinically important changes including targeted therapies and curative HSCT for patients with X-linked lymphoproliferative syndrome (XIAP), X-linked hyper IgM syndrome (CD40L), severe combined immune deficiency (ADA) and subcutaneous panniculitis-like T-cell lymphoma (HAVCR2).